KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Operating Expenses (2016 - 2025)

Astrana Health's Operating Expenses history spans 16 years, with the latest figure at $936.8 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 108.05% year-over-year to $936.8 million; the TTM value through Sep 2025 reached $2.8 billion, up 73.16%, while the annual FY2024 figure was $1.9 billion, 49.39% up from the prior year.
  • Operating Expenses for Q3 2025 was $936.8 million at Astrana Health, up from $634.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $936.8 million in Q3 2025 and bottomed at $11.9 million in Q1 2022.
  • The 5-year median for Operating Expenses is $314.9 million (2023), against an average of $350.1 million.
  • The largest annual shift saw Operating Expenses crashed 92.26% in 2022 before it soared 2536.45% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $192.9 million in 2021, then plummeted by 87.32% to $24.4 million in 2022, then surged by 1360.04% to $356.9 million in 2023, then soared by 86.18% to $664.5 million in 2024, then soared by 40.99% to $936.8 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Operating Expenses are $936.8 million (Q3 2025), $634.5 million (Q2 2025), and $599.8 million (Q1 2025).